arrow
E

Emma Guttman-Yassky

Icahn School of Medicine at Mount Sinai
H指数:115
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate-to-Severe Atopic Dermatitis

胶带剥离转录组学揭示nemolizumab对中重度特应性皮炎患者瘙痒、增生、炎症和细胞外基质标志物的影响

2026-09-050
PRE
Comprehensive molecular profiling of Hispanic, Black, Asian, and White patients with atopic dermatitis via tape strip RNA sequencing and serum proteomics

通过胶带剥离RNA测序和血清蛋白质组学对患有特应性皮炎的西班牙裔、非裔、亚裔和白人患者的全面分子表征

2026-04-250
PRE
Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata

对中度至重度斑秃患者头皮的全面单细胞转录组学分析

2026-02-230
PRE
Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary

使用0.15%罗氟司特乳膏长期治疗≥6岁特应性皮炎患者(INTEGUMENT-OLE临床研究):一份通俗语言摘要

2026-01-010
PRE
Clinical and Molecular Effect of the Anti–IL-18 Antibody Aletekitug in Adults With Atopic Dermatitis

抗IL-18抗体Aletekitug在成人特应性皮炎中的临床与分子效应

2025-12-180
OAAI
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials

罗卡替利单抗治疗中重度特应性皮炎的疗效与安全性:ROCKET-IGNITE和ROCKET-HORIZON两项全球性、双盲、安慰剂对照、随机III期临床研究

2025-11-250
PRE
Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers

鲁索利替尼乳膏显示出快速降低瘙痒和特应性皮炎体征的效果,且与生物标志物相关。

2025-11-190
OAAI
Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles

大规模血液蛋白质组学分析跨越不同炎症性皮肤疾病揭示广泛性免疫失调及独特的生物标志物谱系

2025-11-170
PRE